Veraxa Biotech Holding AG VRXAW
NASDAQ VRXAW
$0.08 -0.01 (-7.89%)
At close: Aug 18, 2026 · 9:30 AM UTC

Veraxa Biotech Holding AG (VRXAW) Debt Ratio (2024 - 2025)

Veraxa Biotech Holding AG (VRXAW) posted quarterly Debt Ratio of 0.04 for Q4 2025, up 44.8% year-over-year from 0.02 in Q4 2024, and up 44.8% quarter-over-quarter from 0.02 in Q4 2024.

Veraxa Biotech Holding AG (VRXAW) Debt Ratio (2024 - 2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXAW) has reported Debt Ratio for 2 consecutive years, with 0.04 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Debt Ratio rose 44.8% year-over-year to 0.04; the TTM figure through Dec 2025 stood at 0.04 (up 44.8% YoY), while the FY2025 annual figure was 0.04, up 44.8% from the prior year.
  • Debt Ratio advanced to 0.04 in Q4 2025 per VRXAW's latest filing, from 0.02 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q4 2025 and bottomed at 0.02 in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 0.04
Dec 31, 2024 0.02